Transcripts Thiogenesis Therapeutics, Corp. OTC Markets

Stocks

Delayed OTC Markets 09:30:19 2026-08-07 EDT			5-day change	1st Jan Change
0.4200 ^USD	+7.69%		0.00%	-28.01%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

No results match your criteria